solifenacin g.l.pharma 10mg potahovaná tableta
g.l. pharma gmbh, lannach array - 17227 solifenacin-sukcinÁt - potahovaná tableta - 10mg - solifenacin
solifenacin g.l.pharma 5mg potahovaná tableta
g.l. pharma gmbh, lannach array - 17227 solifenacin-sukcinÁt - potahovaná tableta - 5mg - solifenacin
jodid draselný g.l. pharma 65mg tableta
g.l. pharma gmbh, lannach array - 1181 jodid draselnÝ - tableta - 65mg - jodid draselnÝ
cerebrolysin ever pharma 215,2mg/ml injekční/infuzní roztok
ever neuro pharma gmbh, unterach array - 1602 cerebrolysin - injekční/infuzní roztok - 215,2mg/ml - jinÁ lÉČiva centrÁlnÍ nervovÉ soustavy
teriflunomide g.l. pharma 14mg potahovaná tableta
g.l. pharma gmbh, lannach array - 15618 teriflunomid - potahovaná tableta - 14mg - teriflunomid
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin-dihydrochloridu - fenylketonurie - jiné zažívací trakt a produkty metabolismu, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
sunitinib g.l. pharma 12,5mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib g.l. pharma 25mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib g.l. pharma 50mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib
cabazitaxel g.l. pharma 20mg/ml koncentrát pro infuzní roztok
g.l. pharma gmbh, lannach array - 18095 kabazitaxel - koncentrát pro infuzní roztok - 20mg/ml - kabazitaxel